According to a recent report by GlobalData, the automation of R&D processes is expected to increase by 50% in the next five years, with a projected market worth $15 billion by 2025. Within India’s dynamic and growing generics, pharma, and chemical market, taking advantage of automation and digital integration will clearly stand out as a critical competitive advantage.

In an increasingly global marketplace, leading science-based companies in India now compete worldwide in every dimension: innovation, productivity, business efficiency and more. In response, organizations constantly seek to streamline operations, accelerate the pace of product development, and reduce the time taken to reach the market.